The effect of non-steroidal anti-inflammatory drugs on medical abortion with mifepristone and misoprostol at 13–22 weeks gestation

Author： Fiala C.   Swahn M.L.   Stephansson O.   Gemzell-Danielsson K.  

Publisher： Oxford University Press

ISSN： 1460-2350

Source： Human Reproduction, Vol.20, Iss.11, 2005-11, pp. : 3072-3077

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13–20 weeks gestation

By Hamoda Haitham   Ashok Premila W.   Flett Gillian M.M.   Templeton Allan  

Human Reproduction, Vol. 20, Iss. 8, 2005-08 ,pp. : 2348-2354

Oxford University Press

Access to resources Recommend Favorite

A prospective randomized comparison of sublingual and oral misoprostol when combined with mifepristone for medical abortion at 12–20 weeks gestation

By Tang Oi Shan   Chan Carina C.W.   Kan Anita S.Y.   Ho Pak Chung  

Human Reproduction, Vol. 20, Iss. 11, 2005-11 ,pp. : 3062-3066

Oxford University Press

Access to resources Recommend Favorite

Non-steroidal anti-inflammatory drugs request parity with Helicobacter pylori

By Ladwa Meera   Takeuchi Ken   Bjarnason Ingvar  

Scandinavian Journal of Gastroenterology, Vol. 41, Iss. 4, 2006-03 ,pp. : 373-375

Informa Healthcare

Access to resources Recommend Favorite

Non-Steroidal Anti-Inflammatory Drugs, Lower Oesophageal Sphincter-Relaxing Drugs and Oesophageal Cancer

By  

Digestion, Vol. 74, Iss. 2, 2007-02 ,pp. : 109-115

Karger

Access to resources Recommend Favorite

Use of Non-Selective Non-Steroidal Anti-Inflammatory Drugs in Relation to Cardiovascular Events. A Systematic Pharmacoepidemiological Review

By  

Current Vascular Pharmacology, Vol. 14, Iss. 6, 2016-10 ,pp. : 502-513

Bentham Science Publishers

Access to resources Recommend Favorite